We are researching for a Life without Cancer!
Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances #chemotherapy efficacy in #Ewing #sarcoma
tinyurl.com/3kcs3bc9
@dkfz.bsky.social
@uniheidelberg.bsky.social
@nct-heidelberg.bsky.social
Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances #chemotherapy efficacy in #Ewing #sarcoma
tinyurl.com/3kcs3bc9
@dkfz.bsky.social
@uniheidelberg.bsky.social
@nct-heidelberg.bsky.social
Learn More in Immunity @cellpress.bsky.social
www.cell.com/immunity/abs...
Learn More in Immunity @cellpress.bsky.social
www.cell.com/immunity/abs...
📘 In our #Immunometabolism 2025 collection: rupress.org/jem/collecti...
📘 In our #Immunometabolism 2025 collection: rupress.org/jem/collecti...
You can find the full story here www.science.org/doi/10.1126/...
@verenaresch.bsky.social did a wonderful job on the cover and animation, she really brought it to life 👩🎨
Learn more in this week's issue: scim.ag/3FA3Ygq
You can find the full story here www.science.org/doi/10.1126/...
@verenaresch.bsky.social did a wonderful job on the cover and animation, she really brought it to life 👩🎨
Comprehensive #DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature gene
tinyurl.com/42fxmmud
@dkfz.bsky.social
@uniheidelberg.bsky.social
Comprehensive #DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature gene
tinyurl.com/42fxmmud
@dkfz.bsky.social
@uniheidelberg.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...